PB1883: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINOTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS INDUCES DEEP REMISSIONS: EARLY RESULTS OF AN ONGOING PH...

por Burger, J., Sivina, M., Kim, E., Issa, G., Wierda, W., Jain, N., Thompson, P., Ferrajoli, A.
Publicado 2022